A Sneaky Culprit: Secondary Infectious Keratitis Due to Brevundimonas diminuta.

IF 2.1 4区 医学 Q2 OPHTHALMOLOGY
Suma K Thareja, Susan Luo, Sarah Carballo
{"title":"A Sneaky Culprit: Secondary Infectious Keratitis Due to Brevundimonas diminuta.","authors":"Suma K Thareja, Susan Luo, Sarah Carballo","doi":"10.1097/ICL.0000000000001170","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To describe a rare case of infectious keratitis secondary to Brevundimonas diminuta , a gram-negative bacillus with fluoroquinolone resistance and rare clinical isolation.</p><p><strong>Methods: </strong>A 50-year-old man with contact lens overuse presented with a large corneal ulcer and hand motion visual acuity. Initial treatment with fortified topical tobramycin and vancomycin yielded slow improvement, and initial culture grew Staphylococcus epidermidis , Staphylococcus hominis , and Corynebacterium bovis . Therapy was tapered to topical moxifloxacin. Loteprednol was added to reduce corneal inflammation after presumed sterilization. Persistent epithelial defect and worsening infiltrate after 3 weeks prompted repeat culture and corneal punch biopsy.</p><p><strong>Results: </strong>Repeat culture revealed B. diminuta resistant to moxifloxacin. Treatment was modified to tobramycin, and therapeutic penetrating keratoplasty was pursued to prevent further stromal loss. Four months postoperatively, the cornea remained clear without recurrence or neovascularization.</p><p><strong>Conclusion: </strong>To our knowledge, this is the second reported culture-positive case of secondary infectious keratitis with B. diminuta , highlighting its rarity and potential for delayed identification. The atypical response to initial therapy underscores the importance of repeat cultures and corneal biopsy in persistent cases. This case contributes to the growing understanding of rare ocular pathogens, advocating for a vigilant clinical approach.</p>","PeriodicalId":50457,"journal":{"name":"Eye & Contact Lens-Science and Clinical Practice","volume":" ","pages":"244-246"},"PeriodicalIF":2.1000,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eye & Contact Lens-Science and Clinical Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/ICL.0000000000001170","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To describe a rare case of infectious keratitis secondary to Brevundimonas diminuta , a gram-negative bacillus with fluoroquinolone resistance and rare clinical isolation.

Methods: A 50-year-old man with contact lens overuse presented with a large corneal ulcer and hand motion visual acuity. Initial treatment with fortified topical tobramycin and vancomycin yielded slow improvement, and initial culture grew Staphylococcus epidermidis , Staphylococcus hominis , and Corynebacterium bovis . Therapy was tapered to topical moxifloxacin. Loteprednol was added to reduce corneal inflammation after presumed sterilization. Persistent epithelial defect and worsening infiltrate after 3 weeks prompted repeat culture and corneal punch biopsy.

Results: Repeat culture revealed B. diminuta resistant to moxifloxacin. Treatment was modified to tobramycin, and therapeutic penetrating keratoplasty was pursued to prevent further stromal loss. Four months postoperatively, the cornea remained clear without recurrence or neovascularization.

Conclusion: To our knowledge, this is the second reported culture-positive case of secondary infectious keratitis with B. diminuta , highlighting its rarity and potential for delayed identification. The atypical response to initial therapy underscores the importance of repeat cultures and corneal biopsy in persistent cases. This case contributes to the growing understanding of rare ocular pathogens, advocating for a vigilant clinical approach.

一个鬼鬼祟祟的罪魁祸首:由微小短单胞菌引起的继发性感染性角膜炎。
目的:报道一例罕见的革兰氏阴性耐氟喹诺酮杆菌继发传染性角膜炎的病例。方法:50岁男性,因过度使用隐形眼镜而出现大面积角膜溃疡及手部运动视力。最初局部强化妥布霉素和万古霉素治疗效果缓慢,最初培养出表皮葡萄球菌、人型葡萄球菌和牛链杆菌。治疗逐渐减少到局部莫西沙星。在假定消毒后,加入洛特泼诺以减少角膜炎症。持续的上皮缺损和3周后恶化的浸润提示重复培养和角膜穿孔活检。结果:重复培养显示小芽胞杆菌对莫西沙星耐药。治疗改为妥布霉素,并进行穿透性角膜移植术以防止进一步的间质损失。术后4个月,角膜保持清晰,无复发或新生血管形成。结论:据我们所知,这是第二例报道的继发性传染性角膜炎伴小芽胞杆菌培养阳性病例,突出了其罕见性和延迟识别的潜力。对初始治疗的非典型反应强调了在持续病例中重复培养和角膜活检的重要性。该病例有助于加深对罕见眼部病原体的了解,倡导警惕的临床方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.50
自引率
4.30%
发文量
150
审稿时长
6-12 weeks
期刊介绍: Eye & Contact Lens: Science and Clinical Practice is the official journal of the Contact Lens Association of Ophthalmologists (CLAO), an international educational association for anterior segment research and clinical practice of interest to ophthalmologists, optometrists, and other vision care providers and researchers. Focusing especially on contact lenses, it also covers dry eye disease, MGD, infections, toxicity of drops and contact lens care solutions, topography, cornea surgery and post-operative care, optics, refractive surgery and corneal stability (eg, UV cross-linking). Peer-reviewed and published six times annually, it is a highly respected scientific journal in its field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信